SPECTRUM PHARMACEUTICALS INC — Net Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/45bc7124-ccaf-4c77-b26f-c69a674b854f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-75.4M | 2022-01-01 – 2022-12-31 | evidence 0000831547-23-000007 |
| FY 2021 | $-158.6M | 2021-01-01 – 2021-12-31 | evidence 0000831547-22-000014 |
| FY 2020 | $-160.9M | 2020-01-01 – 2020-12-31 | evidence 0000831547-21-000009 |
| FY 2019 | $-112.7M | 2019-01-01 – 2019-12-31 | evidence 0000831547-20-000009 |
| FY 2018 | $-120.7M | 2018-01-01 – 2018-12-31 | evidence 0000831547-20-000009 |
| FY 2017 | $-92.2M | 2017-01-01 – 2017-12-31 | evidence 0000831547-20-000009 |
| FY 2016 | $-69.8M | 2016-01-01 – 2016-12-31 | evidence 0000831547-18-000015 |
| FY 2015 | $-52.6M | 2015-01-01 – 2015-12-31 | evidence 0000831547-18-000015 |
| FY 2014 | $-45.7M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091493 |
| FY 2013 | $-62.1M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-094593 |
| FY 2012 | $94.2M | 2012-01-01 – 2012-12-31 | evidence 0001193125-14-094593 |
| FY 2011 | $49.9M | 2011-01-01 – 2011-12-31 | evidence 0001193125-14-094593 |
| FY 2010 | $-48.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-094639 |
| FY 2009 | $-19.0M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-094639 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SPECTRUM PHARMACEUTICALS INC — all facts · Revenue · Operating Income